Brand Strategy, Naming, Identity, Collateral, Copywriting, Website Design and Development
Qrons, a preclinical biotech company is engaged in research to find treatment to combat neurological injuries. Already publicly traded, the start-up came to Comet to develop the brand’s story: to take the founder’s passion, intelligence and unique business perspective to attract investors and research partners.
Project Outcomes | ROI
Strengthened appeal of company’s vision to investors and research partners; secured research support of Dartmouth College; successfully raised investor engagement and site traffic retention.
Neurons, or nerve cells, are not visually appealing because they have long tails called axons. By sketching and simplifying the main characteristics of a neuron, we designed an elegant mark to represent the company’s research focus of traumatic brain injury. Emphasizing the “Q” with a controlled typography pulls the logo together.
Qrons has one office in New York and a research lab at Ariel University in Israel, so we presented the UX design and received feedback through remote Skype screen-share meetings. Designed for mobile-first users, the clean design along with concise messaging, the site directs users quickly to content most relevant to their interests.
The strategy was to pair concise messaging with a clean design to direct users to the areas most relevant to their interests.
Depicting Qrons’ mark graphically strengthens the brand’s visual style—uncomplicated and effective.
We automated the Investor Relations section of the website to meet SOX compliance standards. The website updates with live stock data, press releases and SEC filings. The client can easily export the data for investor presentations.